APSR2026-145

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP11-002
P44
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1210841-46904-(Ji-Su Shim) APSR 2026 poster_434162.pdf
Format: PDF Only
09. Asthma
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

JISU SHIM * Ewha Womans University Internal Medicine Seoul Korea, ROK (South)
Kyung-Min Ahn - Ewha Womans University Internal Medicine Seoul Korea, ROK (South)
Min-Hye Kim - Ewha Womans University Internal Medicine Seoul Korea, ROK (South)
Young-Joo Cho - Ewha Womans University Internal Medicine Seoul Korea, ROK (South)
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
JISU
SHIM
amzm@naver.com
+821054832214
31-40
 
Original Research
Distinct Serum Metabolic Signatures in Obese Versus Normal-Weight Asthma
Maximum 25 words
Abstract Content
Obesity is a significant comorbidity that complicates asthma management and influences its inflammatory endotype. This study aimed to characterize serum metabolic profiles distinguishing obese from normal-weight asthma patients.
Serum samples from 60 Korean adult asthma patients were analyzed (obese group, body mass index [BMI] ≥25 kg/m², n=30; normal-weight group, BMI <23 kg/m², n=30). Untargeted metabolomic profiling was performed using ultra-performance liquid chromatography–quadrupole time-of-flight (UPLC-Q-TOF) mass spectrometry. Data were processed using UNIFI software and subjected to multivariate statistical analysis including principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA). Differential metabolites were identified using variable importance in projection (VIP) scores and one-way ANOVA. P-values were adjusted using the false discovery rate (FDR) to account for multiple comparisons.
Baseline lung function and airway inflammatory markers (forced expiratory volume in one second [FEV1], fractional exhaled nitric oxide [FeNO], eosinophil count, and total immunoglobulin E) were comparable between groups. In contrast, obese asthma patients exhibited higher systemic inflammatory markers, including C-reactive protein (0.69 vs 0.07 mg/dL, p=0.009) and total leukocyte count (7.32 vs 6.17 ×10⁹/L, p=0.038). PLS-DA demonstrated clear separation between obese and normal-weight asthma groups (R²Y = 0.602, Q² = 0.445; permutation p = 1.77×10⁻⁶), indicating distinct metabolic profiles. After multiple testing correction, fumarylcarnitine, tetradecasphinganine, and lysophosphatidylcholine (LPC) 20:4 were significantly increased in obese asthma, whereas LPC 18:2 and LPC 16:0 were decreased (FDR < 0.05). Heatmap analysis supported clustering patterns consistent with lipid remodeling and altered mitochondrial fatty acid oxidation pathways in obese asthma.
Our findings demonstrate distinct serum metabolic signatures in obese asthma patients, particularly involving acylcarnitine and phospholipid metabolism, reflecting altered lipid remodeling and mitochondrial fatty acid oxidation. Integration with cytokine profiling and multi-omics analyses may further elucidate the underlying mechanistic pathways and identify potential metabolic biomarkers in obese asthma.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Asthma, Obesity, Metabolomics
maximum 3 keywords and no abbreviations, separated by commas
This study was supported by a grant from The Korean Academy of Asthma, Allergy and Clinical Immunology (KAAACI 2024-04).
311